Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

1,274 total articles

Catheter Precision Engages Strategic Advisor

Catheter Precision Engages Strategic Advisor

Catheter Precision, Inc. announced engagement of a strategic advisor to market its cardiac electrophysiology business for sale. This move intends to unlock shareholder value by monetizing legacy medical device assets and concentrating on the company's growing Flyte aviation platform. The cardiac electrophysiology products LockeT and VIVO, both FDA-…

Top Ships Announces Filing of 2025 Annual Report on Form 20-F

Top Ships Announces Filing of 2025 Annual Report on Form 20-F

TOP Ships Inc., an international operator of modern eco tanker vessels, announced the filing of its 2025 annual report on Form 20-F with the U.S. Securities and Exchange Commission. The report is available on both the company's and SEC’s websites. The company reiterates caution on forward-looking statements due to inherent uncertainties.

Osisko Development Announces Annual Grant of Incentive Awards

Osisko Development Announces Annual Grant of Incentive Awards

Osisko Development Corp. announced its annual grant of incentive awards consisting of 1,104,400 stock options and 1,426,600 restricted share units to senior officers and employees under its equity incentive plan. The options are exercisable at C$4.51 per share and will vest over three years, with the RSUs cliff vesting in 2029 subject to performanc…

EYLEA HD® (aflibercept) Approved by FDA as First and Only Injectable Anti-VEGF with Dosing Intervals Up to 5 Months for Wet Age-related Macular Degeneration (wAMD) and Diabetic Macular Edema (DME)

EYLEA HD® (aflibercept) Approved by FDA as First and Only Injectable Anti-VEGF with Dosing Intervals Up to 5 Months for Wet Age-related Macular Degeneration (wAMD) and Diabetic Macular Edema (DME)

The FDA approved Regeneron's EYLEA HD (aflibercept) for extended dosing intervals up to 20 weeks for patients with wet age-related macular degeneration and diabetic macular edema, based on 96-week data from pivotal trials demonstrating sustained efficacy and safety. This approval marks EYLEA HD as the first injectable anti-VEGF with dosing interval…

TransUnion Introduces TruIQ Credit Strategy Studio to Transform How Lenders Build and Launch Prescreen Marketing Campaigns

TransUnion Introduces TruIQ Credit Strategy Studio to Transform How Lenders Build and Launch Prescreen Marketing Campaigns

TransUnion introduced TruIQ Credit Strategy Studio, a self-service platform that drastically reduces prescreen campaign build times for lenders by up to 75%. The tool features no-code, drag-and-drop capabilities, real-time collaboration, and interactive dashboards, streamlining campaign development and enabling faster market responsiveness. Integra…

Diginex Appoints Chief Operating Officer and Chief Administrative Officer to Accelerate Implementation of Business Strategy

Diginex Appoints Chief Operating Officer and Chief Administrative Officer to Accelerate Implementation of Business Strategy

Diginex Limited appoints Jacob Friedman as Chief Operating Officer and Sandra Kovacheva as Chief Administrative Officer to accelerate the integration of its four operating entities into a unified global platform. These leadership enhancements aim to boost operational efficiency, governance, and compliance as Diginex advances its strategy to deliver…

Roadzen to Present at Maxim Group’s “Powering the AI Revolution” Virtual Conference on Tuesday April 7, 2026 at 8:30am ET

Roadzen to Present at Maxim Group’s “Powering the AI Revolution” Virtual Conference on Tuesday April 7, 2026 at 8:30am ET

Roadzen Inc., a Nasdaq-listed AI company integrating insurance and mobility solutions, announced it will present at the 'Powering the AI Revolution' virtual conference hosted by Maxim Group. The presentation will highlight Roadzen’s AI-driven technology that enhances safety, reduces claims costs, and improves underwriting across international marke…

As AI Collides with Legacy Contact Center Technology, TTEC Digital’s Latest Software Release Is Rewriting the Enterprise AI Playbook

As AI Collides with Legacy Contact Center Technology, TTEC Digital’s Latest Software Release Is Rewriting the Enterprise AI Playbook

TTEC Digital has introduced AI Gateway, a software solution that enables enterprises to integrate modern AI capabilities with existing contact center technology without costly system overhauls. The platform supports connections with leading AI providers and CX systems, allowing clients to deploy, test, and scale AI flexibly, resulting in early repo…

Freshworks Expands IT Asset Management Capabilities by Adding Continuous Infrastructure Discovery and Dependency Mapping to Freshservice

Freshworks Expands IT Asset Management Capabilities by Adding Continuous Infrastructure Discovery and Dependency Mapping to Freshservice

Freshworks Inc. has upgraded its Freshservice platform by integrating continuous infrastructure discovery and dependency mapping into its IT Asset Management capabilities. The enhanced platform combines IT Service Management and IT Operations Management with a high-integrity, AI-powered Configuration Management Database (CMDB) to improve data accur…

Orrstown Financial Services, Inc. Ranked #1 in Pennsylvania and #12 Nationally in the S&P Global Market Intelligence 2025 Ranking of Top 50 Best-Performing Community Banks

Orrstown Financial Services, Inc. Ranked #1 in Pennsylvania and #12 Nationally in the S&P Global Market Intelligence 2025 Ranking of Top 50 Best-Performing Community Banks

Orrstown Financial Services, Inc., the holding company for Orrstown Bank, announced it has been ranked the top-performing community bank in Pennsylvania and 12th nationally in the S&P Global Market Intelligence 2025 rankings for banks with $3 billion to $10 billion in assets. The ranking reflects the company's strong financial performance, discipli…

Revolution Medicines Begins Treating Patients in Phase 3 RASolute 303 Trial Evaluating Daraxonrasib as First Line Treatment for Patients with Metastatic Pancreatic Cancer

Revolution Medicines Begins Treating Patients in Phase 3 RASolute 303 Trial Evaluating Daraxonrasib as First Line Treatment for Patients with Metastatic Pancreatic Cancer

Revolution Medicines has started treating patients in the global Phase 3 RASolute 303 trial evaluating daraxonrasib as monotherapy and in combination with chemotherapy for untreated metastatic pancreatic ductal adenocarcinoma (PDAC). This trial aims to improve treatment outcomes for a cancer with high unmet medical need and poor prognosis. Daraxonr…

Bionano Announces Publication from Johns Hopkins and MD Anderson Showing that OGM can Outperform Traditional Methods in Analysis of Multiple Myeloma

Bionano Announces Publication from Johns Hopkins and MD Anderson Showing that OGM can Outperform Traditional Methods in Analysis of Multiple Myeloma

Bionano Genomics announced a study published in the American Journal of Hematology demonstrating that their optical genome mapping (OGM) technology significantly outperforms traditional cytogenetic methods such as karyotyping, FISH, and next-generation sequencing in analyzing multiple myeloma. The study, involving the largest MM cohort to date and …

Gold.com Acquires Sunshine Minting, Creating One of North America’s Largest Precious Metals Minting Platforms

Gold.com Acquires Sunshine Minting, Creating One of North America’s Largest Precious Metals Minting Platforms

Gold.com, Inc. (NYSE: GOLD) has acquired Sunshine Minting, Inc. in an all-cash transaction, consolidating its stake to 100% ownership. The acquisition significantly expands Gold.com's vertically integrated minting platform, increasing production capacity to over three million ounces of finished precious metals products per week across Sunshine Mint…